Takeda’s IBD Superheroes ad is pharma’s North Carolina Tarheels, winning the championship in our first DTC advertising tournament.

After a year of nothing but bad news about FDA citations of its plants, India’s Alkem Laboratories has announced something positive.

Takeda is letting go of 180 of the nearly 300 employees picked up in its $5.2 billion buyout of Ariad but says some of those may still land jobs in its global…

WuXi AppTec started IPO prep for core drug R&D, Purdue and Shionogi won approval for a new constipation med, and an Indian CRO's meds were halted by…

A rotavirus vaccine candidate showed better efficacy than Merck’s and GlaxoSmithKline’s approved vaccines in a late-stage trial.

China plans to eliminate major regulatory barriers for foreign drugs, Tessa bought Euchloe for its checkpoint inhibitors, and J&J and Lilly CEOs supported…

An Indian drugmaker whose Mumbai plant got nailed by an FDA warning letter several years ago is again under the gun for making some of the same mistakes at a…

In what could be a direct rebuttal to President Donald Trump’s view on foreign trade, Eli Lilly CEO David Ricks called any promotion of deglobalization “…

Pharma Asia